More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$29.77B
EPS
12.19
P/E ratio
25.8
Price to sales
1.76
Dividend yield
0.786%
Beta
0.841143
Previous close
$363.30
Today's open
$357.25
Day's range
$355.63 - $369.06
52 week range
$244.52 - $373.34
show more
CEO
Adam H. Schechter
Employees
71000
Headquarters
Burlington, NC
Exchange
New York Stock Exchange
Shares outstanding
81200000
Issue type
Common Stock
Healthcare
Medical Diagnostics & Screening
Labcorp Holdings (LH) is a Top-Ranked Momentum Stock: Should You Buy?
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks Investment Research • Nov 5, 2026

Labcorp to Speak at the UBS Global Healthcare Conference
BURLINGTON, N.C., Nov. 4, 2026 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that Chief Financial Officer Julia Wang will speak at the UBS Global Healthcare Conference on November 10 at 8:45 a.m.
PRNewsWire • Nov 4, 2026

Labcorp Holdings (LH) is a Top-Ranked Value Stock: Should You Buy?
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks Investment Research • Oct 30, 2026

Labcorp Holdings: The Optimism May Be Going Overboard (Rating Downgrade)
Labcorp Holdings raised guidance, triggering a sharp stock price rally. I view LH as a compelling long-term growth story, but current valuation is stretched. The price-earnings ratio approaching 20 exceeds my preferred range for LH's fundamentals.
Seeking Alpha • Oct 29, 2026

Labcorp Targets Margin Growth, Absorbs Policy Headwinds
Labcorp Holdings (NYSE:LH) stock is trading at a 52-week high after the company reported upbeat third-quarter earnings and raised its fiscal outlook.
Benzinga • Oct 28, 2026

Labcorp Q3 Earnings Call Highlights
Labcorp NYSE: LH reported third-quarter 2026 revenue growth, margin expansion and double-digit adjusted earnings-per-share growth, prompting the laboratory services company to raise the midpoint of its full-year revenue and earnings outlook.
MarketBeat • Oct 28, 2026

Labcorp Holdings Inc. (LH) Q3 2026 Earnings Call Transcript
Labcorp Holdings Inc. (LH) Q3 2026 Earnings Call Transcript
Seeking Alpha • Oct 28, 2026

Labcorp Reports Strong 2026 Third Quarter Results; Raises Full Year 2026 Guidance
Results from operations for third quarter 2026 versus third quarter 2025: Revenue: $3.81 billion vs. $3.56 billion, up 6.9% Diluted EPS: $3.22 vs.
PRNewsWire • Oct 28, 2026

Labcorp Holdings (LH) Q3 Earnings and Revenues Surpass Estimates
Labcorp Holdings (LH) came out with quarterly earnings of $4.78 per share, beating the Zacks Consensus Estimate of $4.65 per share. This compares to earnings of $4.18 per share a year ago.
Zacks Investment Research • Oct 28, 2026

Compared to Estimates, Labcorp (LH) Q3 Earnings: A Look at Key Metrics
Although the revenue and EPS for Labcorp (LH) give a sense of how its business performed in the quarter ended September 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Zacks Investment Research • Oct 28, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Labcorp Holdings Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.